Catalyst Wire Dossier Catalyst Wire Dossier

ABLE Exoskeleton

· ABLE Human Motion S.L.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABLE Exoskeleton, covering 2024-07-31 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis [NA]

See pricing